Roundtable: Small Cell Lung Cancer Diagnosis & Treatment

Small-cell lung cancer (SCLC) is an aggressive and fast-growing type of lung cancer that is commonly caused by smoking. In this video series, Benjamin Cooper, MD, sits down with Joshua Sabari, MD, and Rajwanth Veluswamy, MD, MSCR, to discuss the diagnostic differences between small cell and non-small cell lung cancers (NSCLC), as well as current and future treatment approaches for SCLC.

Video 1: Lung Cancer Diagnosis & Staging

The panel reviews the steps taken during a patient’s initial evaluation for MCL, risk stratification in order to determine therapy options, and various options and benefits for testing.

Up Next

Video 1: Lung Cancer Diagnosis & Staging
Video 2: SCLC Treatment Approaches
Video 3: The SCLC Pipeline

About the Panel

Dr. Cooper Photo

Benjamin Cooper, MD

  • Moderator
  • Director of Proton Therapy
  • Assistant Professor of Radiation Oncology
  • Laura and Isaac Perlmutter Cancer Center
  • NYU Langone Health
Dr. Sabari Photo

Joshua Sabari, MD

  • Attending Physician
  • Thoracic Medical Oncology
  • Assistant Professor of Medicine
  • NYU Langone Health
Dr. Veluswamy Photo

Rajwanth Veluswamy, MD, MSCR

  • Assistant Professor of Medicine
  • Thoracic Oncology, Tisch Cancer Institute
  • Institute for Translational Epidemiology
  • Ichan School of Medicine at Mount Sinai

Dr. Cooper reports a relationship with IBA.

Dr. Sabari has no financial disclosures to report.

Dr. Veluswamy reports relationships with AstraZeneca, Bristol-Myers Squibb, Merck, and Onconova.